Makers of products containing active ingredients – ranging from pharmaceuticals to perfumes – are increasingly aware that delivery systems are more than just packaging. They are often the enabling technology. Hence, an explosion of new approaches to targeted delivery of actives is coming to market, and we’ve launched the Lux Research Targeted Delivery Intelligence Service to bring you the latest analysis and updates of developments in this expanding field.
Targeted delivery is the collective name for technologies that steer and release active ingredients like drugs, nutrients, flavors, or pesticides to an intended place, time, environment, or other condition. In a recent report, we forecast that today’s $10 billion market for targeted delivery technologies in drugs, medical devices, food, personal care, and agricultural chemicals will grow to $24.6 billion by 2013, with approximately 89% of the market focused on drug delivery.
This week’s graphic highlights a selection of targeted delivery companies, specifically those developing platforms based on bio/chemical targeting. The companies we evaluated exploit a huge diversity of technologies, ranging from recombinant analogs of human proteins to light-activated compounds. As the Grid shows, Halozyme and Starpharma are emerging as Dominant winners driven by good clinical results and multi-million dollar milestone payments from top-tier partners. Companies like Armagen are in the High-potential quadrant with potentially breakthrough technologies getting drugs across the blood-brain barrier, but many have yet to achieve their business potential. Armagen has funding of just $15 million so far.
In the next two to ten years, developers like Halozyme and Starpharma have the potential to own blockbuster platforms that, like blockbuster drugs and diagnostics, and sell products for more than $1 billion annually. But fast followers will force them to keep improving in new and different directions, paralleling the “stent wars,” with breakthroughs and lawsuits aplenty.
Source: Lux Research report “Ranking Targeted Delivery Technologies on the Lux Innovation Grid.”